期刊文献+

雷帕霉素药物支架稳定性试验研究

Experimental study on the stability of rapamycin drug- eluting stent
下载PDF
导出
摘要 目的对雷帕霉素涂层支架在室温下的贮存稳定性进行研究,以确定其有效期。方法将3个批号的产品放置于恒温培养箱内,设定不同温度,测定不同时间的药物含量、药物纯度、聚合物分子量、体外释放、无菌、球囊性能等。结果在稳定性研究的15个月时间内,各项检测指标符合标准。结论本文进行的产品稳定性研究数据可以作为本品的有效期及贮存方法的确立依据。 Objective To research the stability of rapamycin coated stents in room temperature in order to determine its validity period. Methods Three batches of the product were placed in the constant temperature incubator and set different temperature. To detected drug content,purity,molecular weight of polymer,in vitro release,sterile and balloon performance of the products at different time. Results In the study of the stability of 15 months, all the indices met the standard. Conclusion Stability data of the products could be established as the effective period of this products and storage methods.
出处 《药学研究》 CAS 2013年第8期467-469,共3页 Journal of Pharmaceutical Research
关键词 雷帕霉素 药物支架 药物载体 扩张球囊 Rapamycin Drug - eluting stent Drug carrier Balloon
  • 相关文献

参考文献3

二级参考文献23

  • 1宋现涛,杜梦阳,陈欣,苑飞,周玉杰,吕树铮,陈韵岱.采用光学相干断层成像技术评价国产雷帕霉素洗脱支架术内膜覆盖情况[J].心肺血管病杂志,2010,29(S1):79-80. 被引量:1
  • 2乐健,方玮,陈桂良,陈执中.不同包装对甲钴胺注射剂光稳定性影响的研究[J].中国药学杂志,2007,42(10):783-786. 被引量:7
  • 3Rber L,Kelbk H,Ostoijc M,et al.Effect of biolimus-elutingstents with biodegradable polymer vs bare-metal stents on cardio-vascular events among patients with acute myocardial infarction:the COMFORTABLE AMI randomized trial.JAMA,2012,308:777-787.
  • 4Wallace EL,Abdel-Latif A,Charnigo R,et al.Meta-analysis oflong-term outcomes for drug-eluting stents versus bare-metalstents in primary percutaneous coronary interventions for ST-Seg-ment elevation myocardial infarction.Am J Cardiol,2012,109:932-940.
  • 5Neumann FJ,Widimsky P,Belardi JA.One-year outcomes ofpatients with the zotarolimus-eluting coronary stent:RESOLUTEinternational Registry.EuroIntervention.2012,7:1181-1188.
  • 6Stenestrand U,James SK,Lindbck J,et al.Safety and efficacyof drug-eluting vs.bare metal stents in patients with diabetesmellitus:long-term follow-up in the Swedish coronary angiogra-phy and angioplasty registry(SCAAR).Eur Heart J,2010,31:177-186.
  • 7Vink MA,Dirksen MT,Suttorp MJ,et al.5-year follow-up afterprimary percutaneous coronary intervention with a paclitaxel-elu-ting stent versus a bare-metal stent in acute ST-segment elevationmyocardial infarction:a follow-up study of the PASSION(Pacli-taxel-Eluting Versus Conventional Stent in Myocardial Infarctionwith ST-Segment Elevation)trial.JACC Cardiovasc Interv,2011,4:24-29.
  • 8Jeger R,Pfisterer M,Alber H,et al.Newest-generation drug-e-luting and bare-metal stents combined with prasugrel-based anti-platelet therapy in large coronary arteries:the Basel stent kosteneffektivitts trial prospective validation examination partⅡ(BASKET-PROVEⅡ)trial design.Am Heart J,2012,163:136-141.
  • 9Spaulding C,Teiger E,Commeau P,et al.Four-year follow-upof TYPHOON(trial to assess the use of the CYPHer sirolimus-e-luting coronary stent in acute myocardial infarction treated withBallOON angioplasty).JACC Cardiovasc Interv,2011,4:14-23.
  • 10Van den Branden BJ,Rahel BM,Laarman GJ,et al.Five-yearclinical outcome after primary stenting of totally occluded nativecoronary arteries:a randomised comparison of bare metal stentimplantation with sirolimus-eluting stent implantation for the treat-ment of total coronary occlusions(PRISON II study).EuroInter-vention,2012,7:1189-1196.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部